| Literature DB >> 31031005 |
Denis A Mogilenko1, Joel T Haas1, Laurent L'homme1, Sébastien Fleury1, Sandrine Quemener1, Matthieu Levavasseur2, Coralie Becquart2, Julien Wartelle1, Alexandra Bogomolova1, Laurent Pineau1, Olivier Molendi-Coste1, Steve Lancel1, Hélène Dehondt1, Celine Gheeraert1, Aurelie Melchior1, Cédric Dewas1, Artemii Nikitin1, Samuel Pic1, Nabil Rabhi3, Jean-Sébastien Annicotte3, Seiichi Oyadomari4, Talia Velasco-Hernandez5, Jörg Cammenga5, Marc Foretz6, Benoit Viollet6, Milica Vukovic7, Arnaud Villacreces7, Kamil Kranc7, Peter Carmeliet8, Guillemette Marot9, Alexis Boulter10, Simon Tavernier11, Luciana Berod12, Maria P Longhi13, Christophe Paget14, Sophie Janssens15, Delphine Staumont-Sallé2, Ezra Aksoy16, Bart Staels1, David Dombrowicz17.
Abstract
Innate immune responses are intricately linked with intracellular metabolism of myeloid cells. Toll-like receptor (TLR) stimulation shifts intracellular metabolism toward glycolysis, while anti-inflammatory signals depend on enhanced mitochondrial respiration. How exogenous metabolic signals affect the immune response is unknown. We demonstrate that TLR-dependent responses of dendritic cells (DCs) are exacerbated by a high-fatty-acid (FA) metabolic environment. FAs suppress the TLR-induced hexokinase activity and perturb tricarboxylic acid cycle metabolism. These metabolic changes enhance mitochondrial reactive oxygen species (mtROS) production and, in turn, the unfolded protein response (UPR), leading to a distinct transcriptomic signature with IL-23 as hallmark. Interestingly, chemical or genetic suppression of glycolysis was sufficient to induce this specific immune response. Conversely, reducing mtROS production or DC-specific deficiency in XBP1 attenuated IL-23 expression and skin inflammation in an IL-23-dependent model of psoriasis. Thus, fine-tuning of innate immunity depends on optimization of metabolic demands and minimization of mtROS-induced UPR.Entities:
Keywords: IL-23; UPR; dendritic cells; fatty acids; glycolysis; hexokinase; innate immunity; metabolic reprogramming; mtROS; psoriasis
Mesh:
Substances:
Year: 2019 PMID: 31031005 DOI: 10.1016/j.cell.2019.03.018
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582